The Zacks Analyst Blog Highlights: The Boeing, Lockheed Martin, Abbott Labs ... NASDAQ Abbott Labs, along with partner Biogen ( BIIB ), moved daclizumab into a phase III study for the treatment of relapsing-remitting multiple sclerosis ( RRMS ). Abbott Labs is also working on an intestinal gel for advanced Parkinson's disease - the ... |
